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Abstract
The intracellular pathogen Legionella pneumophila hijacks the endoplasmic reticulum (ER)-derived vesicles to create an
organelle designated Legionella-containing vacuole (LCV) required for bacterial replication. Maturation of the LCV involved
acquisition of Rab1, which is mediated by the bacterial effector protein SidM/DrrA. SidM/DrrA is a bifunctional enzyme
having the activity of both Rab1-specific GDP dissociation inhibitor (GDI) displacement factor (GDF) and guanine nucleotide
exchange factor (GEF). LidA, another Rab1-interacting bacterial effector protein, was reported to promote SidM/DrrA-
mediated recruitment of Rab1 to the LCV as well. Here we report the crystal structures of LidA complexes with GDP- and
GTP-bound Rab1 respectively. Structural comparison revealed that GDP-Rab1 bound by LidA exhibits an active and nearly
identical conformation with that of GTP-Rab1, suggesting that LidA can disrupt the switch function of Rab1 and render it
persistently active. As with GTP, LidA maintains GDP-Rab1 in the active conformation through interaction with its two
conserved switch regions. Consistent with the structural observations, biochemical assays showed that LidA binds to GDP-
and GTP-Rab1 equally well with an affinity approximately 7.5 nM. We propose that the tight interaction with Rab1 allows
LidA to facilitate SidM/DrrA-catalyzed release of Rab1 from GDIs. Taken together, our results support a unique mechanism
by which a bacterial effector protein regulates Rab1 recycling.
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Introduction
Rab GTPases play a crucial role in vesicular trafficking through
shuttling between cytosol and membranes, a process that is
controlled by several regulatory proteins [1–4]. GDP dissociation
inhibitors (GDIs) preferentially interact with and deliver GDP-
bound Rabs to their target membranes, where dissociation of the
GDI-Rab complexes is catalyzed by GDI displacement factors
(GDFs) [5–8]. Prenylation at the C-termini of Rab proteins is
essential for their membrane association [9–11]. The membrane-
localized Rabs are subsequently activated by specific guanine
nucleotide exchange factors (GEFs) via promoting their exchange
of GDP for GTP [12–15]. The activated Rabs then bind their
cognate effectors, triggering signaling for vesicle formation [16,17],
vesicle transport [18–23], vesicle tethering and fusion of vesicles
with target membranes [17,24–27]. GTPase activating proteins
(GAPs) catalyze hydrolysis of GTP in the activated Rabs and
return them to the GDP-bound inactive form that is sensitive to
membrane retrieval by GDIs, thus replenishing the cytoplasmic
pool of Rab proteins [4,14,15].
The intracellular bacterial pathogen Legionella pneumophila (L.
pneumophila) is the causative agent of pneumonia Legionnaires
disease [8,28]. Following invasion of host cells, L. pneumophila
resides in the LCV [29] that escapes endolysosomal destruction
[30]. The bacterial effector proteins, delivered by the type IV
secretion system (T4SS) of L. pneumophila into the cytosol of host
cells [31], actively remodel the LCV to establish an intracellular
niche indispensable to bacterial pathogenesis [32]. For example,
the early secretory vesicles from ER can be hijacked to the LCV,
converting it into an ER-derived organelle that supports bacterial
replication [33–36]. Rab1, required for vesicle trafficking between
ER and the Golgi complex [18,37,38], is one of the host proteins
recruited to the LCV shortly after uptake of L. pneumophila [39–41].
Rab1 recruitment subsequently promotes transport and fusion of
ER-derived vesicles with the LCV, thus playing an essential role in
the biogenesis of this organelle [42,43]. The effector protein
SidM/DrrA, by acting as a Rab1-sepcific GEF and GDF, is
required for LCV recruitment of Rab1 [44,45]. Further, the
AMPylation activity of SidM/DrrA modified Rab1 by covalently
adding adenosine monophosphate (AMP) to avoid the GAP
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generating de-AMPylated Rab1 accessible for inactivation by
LepB [43,47]. Another translocated effector protein LidA is also
involved in the recruitment of early secretory vesicles to the LCV
[48,49]. LidA was found to interact with Rab1 as well, regardless
of nucleotide binding states, and promote SidM/DrrA activity of
transporting Rab1 to the LCV [39,45]. Unlike SidM/DrrA
mutants, however, L. pneumophila mutants lacking LidA displayed a
temporal delay but not a loss of Rab1 recruitment to the LCV
[39]. Intriguingly, while indispensable to the recruitment of wild
type Rab1, SidM/DrrA is not required to accumulate Rab1
mutant (D44N) that loses interaction with GDIs but not with LidA
about the LCV [45]. These results suggest that GDIs play a
negative role in Rab1 recruitment by the LCV during L.
pneumophila infection. Recruitment of this Rab1 mutant, however,
is dependent on LidA, suggesting that interaction with Rab1 is
important for the role of LidA in delivering Rab1 to the LCV.
Currently the mechanisms of how LidA cooperates with SidM/
DrrA for Rab1 recruitment are not well understood.
Here, we present the crystal structures of LidA (residues 224-
559) in complex with a GDP-bound Rab1 mutant (S25N; residues
1-176) [50,51] and LidA (residues 188-449) in complex with GTP-
bound Rab1 (residues 1-176). Unexpectedly, the structures showed
that GDP-Rab1(S25N), a ‘‘constitutively’’ inactive mutant,
adopted an active conformation when bound by LidA. In
agreement with the structural observation, biochemical assays
demonstrated that GDP-Rab1(S25N) and GTP-Rab1(Q70L) [52]
exhibited a similar and exceptionally high binding affinity for
LidA. Coupled with previous observations, data presented in
current study support a unique mechanism by which LidA
interferes with the host secretory vesicular trafficking.
Results
LidA binds both GDP and GTP bound Rab1 with a similar
affinity
The Rab1-interacting domain of LidA used in our study is
similar to the one (residues 191-600) necessary and sufficient to
disrupt the secretory pathway when overexpressed in COS1 cells
[49]. Consistently, In vitro data shows truncation of 188 residues
from the N-terminal side or 155 residues from the C-terminal side
of LidA generated no effect on the formation of such a complex
(Figure S1). To further validate the interaction between LidA and
Rab1, we measured their binding affinity using isothermal titration
calorimetry (ITC) technique. The ITC results showed that the
LidA fragment 188-580 containing the predicted coiled-coil
domain interacted with the constitutively active mutant
Rab1(Q70L) with a dissociation constant of 7.5 nM (Figure 1A).
Surprisingly, the same protein also bound nearly equally well to
the constitutively GDP-bound mutant of Rab1(S25N), with a
dissociation constant of 7.6 nM (Figure 1B). A preference of LidA
for the GTP-Rab1 could result from a lower abundance of GDP-
Rab1 in cells.
Overall structures of LidA and its complex with Rab1
To reveal the molecular basis for the LidA-Rab1 interaction, we
first solved the crystal structure of LidA(224-559) in complex with
a constitutively GDP-bound mutant Rab1(S25N; 1-176) at 1.73 A ˚
using molecular replacement (Table S1 in supporting informa-
tion).
The overall LidA-Rab1 complex adopts a compact and globular
structure (Figures 2A,B). The interaction between LidA and Rab1
resulted in a 1:1 stoichiometric complex and buried 41%
(4031 A ˚ 2/9845 A ˚ 2) of the Rab1. The exceptionally large buried
surface generated by LidA-Rab1 interaction is consistent with
their strong binding affinity. In the structure, Rab1 is held in a
large and pronounced groove made by the four ‘‘fingers’’ with an
extensive, though not complete, charge and surface complemen-
tarities. Contacts between LidA and Rab1 are established through
a combination of hydrogen bonds and hydrophobic interactions
Figure 1. Measurement of binding affinity between LidA and
GTP-bound or GDP-bound Rab1 by ITC. (A) Raw ITC data. Top
panel: twenty injections of GTP-bound Rab1(Q70L) solutions were
titrated into LidA(188-580) solution in ITC cell. The area of each injection
peak corresponds to the total heat released for that injection. Bottom
panel: the binding isotherm for GTP-bound Rab1(Q70L) and LidA(188-
580) interaction, the integrated heat is plotted against the stoichiom-
etry of 1:1, data fitting revealed a binding affinity of 7.5 nM. (B) Top
panel: twenty injections of GDP-bound Rab1(S25N) solutions were
titrated into LidA(188-580) solution in ITC cell. The area of each injection
peak corresponds to the total heat released for that injection. Bottom
panel: the binding isotherm for GDP-bound Rab1(S25N) and LidA(188-
580) interaction, the integrated heat is plotted against the stoichiom-
etry of 1:1, data fitting revealed a binding affinity of 7.6 nM. Both
titrations were performed in the absence of added Mg
2+ and GDP/GTP.
doi:10.1371/journal.ppat.1002528.g001
Author Summary
Legionella pneumophila delivers 275 validated substrates
into the host cytosol by its Dot/Icm type IV secretion
system. Several substrates including SidM/DrrA and LidA
directly interact with the host Rab GTPases and interfere
with the vesicle secretion pathway. SidM/DrrA is necessary
for Rab1 recruitment, function as a Rab1 specific GDI
displacement factor and guanine nucleotide exchange
factor. LidA has the auxiliary activity for Rab1 recruitment,
whereas it is more important for the formation of the
replication vacuole compared with SidM/DrrA. LidA is
predicted to be the first substrate secreted by the Dot/Icm
system and is critical for maintaining the integrity of the
bacterial cell. Moreover, it expresses throughout the
intracellular growth phase, localizes to early secretory
compartments, and interacts with several members of Rab
family. Here we present the crystal structures of LidA
coiled-coil domain in complex with two different states of
Rab1, GDP- and GTP-bound. The GDP-bound Rab1 in the
complex surprisingly has the same conformation with the
GTP-bound Rab1, revealing that LidA can retain Rab1
persistently in its active state. Our structures add a new
insight into the regulation of the host Rab1 membrane
cycle by pathogen-secreted coiled-coil effector.
Structural Insights into LidA Recognizing Rab1
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(Figure 2B).
LidA (residues 224-559) is composed of seven a-helices and ten
b-strands, which arrange into a structure resembling a hand with
the baby finger buried in the palm and the remaining four
straightened (Figure 2C). Six of the seven a-helices form three
extended two-stranded a-helical coiled-coils. This structural
observation supports a previous prediction that LidA is a coiled-
coil rich structure [48,49]. Two of them, made by a4/a5 and a1/
a7, are the ‘‘index finger’’ and the ‘‘middle finger’’, respectively.
Interaction between them is primarily mediated by packing of a1
against a5. The ‘‘thumb’’ stems from a two-helix coiled-coil
formed by a2 and a3 helices which interact with the base of
‘‘index finger’’ through packing against a4. The isolated helix a6
and its following loop make extensive hydrophobic contacts with
three anti-parallel b-sheets (b5/b6, b7/b8 and b9/b10), resulting
in formation of the ‘‘ring finger’’. The N-terminal side of a4,
which is not involved in the formation of coiled-coil structures,
tightly contacts the two anti-parallel b-sheets (b1/b2 and b3/b4)
located between a3 and a4, thus making the ‘‘wrist’’. Interestingly,
the a1 and a7 stay closely together and form the middle finger.
The terminal parallel helix of LidA extends to the outside of
interacting region, forms an antiparallel long coiled-coil
(Figure 2C). So we suppose the N- and C-terminal domains of
LidA may stay spatially close cooperate with each other to perform
specific function.
Interaction interfaces between LidA and Rab1
In the complex, switch I (residues 33-48) of Rab1 is mainly
sandwiched between the ‘‘middle finger’’ and the ‘‘ring finger’’ by
making contacts with a1, a7 and a6. It also contacts the ‘‘index
finger’’ a5 (Figures 3A,B). Close packing of Ile44
Rab1 from switch I
and Phe73
Rab1 from switch II (residues 65-83) against Leu541
LidA,
Val542
LidA, Val538
LidA, Leu436
LidA, Ala439
LidA, Y243
LidA and
the aliphatic portion of Asn432
LidA (from a5) appears to dominate
the interactions around this interface. Additional van der Waals
interactions result from contacts of Tyr532
LidA with the alpha
carbon atom of Gly21
Rab1 and Tyr40
Rab1, and Ile41
Rab1 with
Leu548
LidA and Glu549
LidA in LidA. Hydrogen bonds further
strengthen this interface. In particular, in addition to forming a salt
bridge with Asp443
LidA, Arg72
Rab1 from the switch II region
makes a hydrogen bonds with the backbone carbonyl of
Met536
LidA. Through an intramolecular hydrogen bond, Ar-
g72
Rab1 is stabilized by the catalytically important residue
Gln70
Rab1, which in turn mediates a bifurcated polar interaction
with the carbonyl oxygen of Thr534
LidA and Glu533
LidA from
LidA.
The C-terminal portion of the switch II, together with the
region defined by b2, b3 and b4, makes extensive contacts with
the base of ‘‘index finger’’ (Figures 3A,C). Center to this interface
are the van der Waals interactions made by Phe48
Rab1 and
Trp65
Rab1 from Rab1 with a cluster of surrounding hydrophobic
residues of LidA. At periphery, a number of hydrogen bonds flank
the hydrophobic interaction center. Among these, Lys61
Rab1 from
Rab1 forms three hydrogen bonds with Asn421
LidA and the
carbonyl oxygen atoms of Ile413
LidA and Ser415
LidA. Other
hydrogen bonds include those formed by Tyr8
Rab1 with the
carbonyl oxygen atom of Met414
LidA, Gln63
Rab1 with Asn410
LidA,
the carbonyl oxygen atoms of Val46
Rab1, ILE44
Rab1 and
Phe73
Rab1 with Asn432
LidA and Asn435
LidA, respectively. In
addition to hydrogen bonding with His431
LidA, Tyr80
Rab1 also
engages hydrophobic contact with Leu406
LidA.
The GDP-bound Rab1(S25N) is held in the active
conformation upon LidA binding
Our biochemical assay (Figures 1A,B) indicates that LidA
binding is independent of the Rab1 nucleotide-binding states. To
understand the underlying molecular mechanisms, we solved the
crystal structure of LidA (residues 188-449) in complex with the
Rab1(WT; residues 1-191) at 2.2 A ˚. The structure of the complex
is highly similar to that of LidA(224-559)-Rab1(S25N) with an
r.m.s.d of 0.678 A ˚ for Rab1; 1.496 A ˚ for LidA, respectively
(Figure 4A). As anticipated, GTP is well defined in the crystal
structure (Figure 4A) and its interactions with Rab1 are conserved
in other active Rabs (Figure S2) [53–55]. Surprisingly, structural
comparison revealed that the conformation of LidA-bound
Rab1(S25N) is essentially identical with that of LidA-bound
GTP-Rab1 (Figure 4B), indicating that Rab1(S25N) is in the active
Figure 2. Overall structures of LidA and its complex with GDP-
bound Rab1. (A) Schematic representation of LidA fingers and Rab1
function regions, sequences not included in the crystallized proteins are
marked with hatched lines and labeled as truncation. (B) Cartoon
representation of the overall structure of LidA(224-559)-Rab1(S25N; 1-
176) complex. Rab1(S25N) is shown in gray, LidA is colored by fingers as
shown in schematic representation, GDP is depicted in sticks. (C)
Cartoon representation of the LidA fingers (left) and schematic
representation of LidA terminal long coiled-coil domain (right), wheat
color represents coiled-coil region in crystal structure, gray color
represents extend a-helix predicted by secondary structure analysis. N,
N terminus; C, C terminus.
doi:10.1371/journal.ppat.1002528.g002
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in the free GDP-Rab1 is completely disordered (Figure 4C), it is
well defined when bound by LidA. As with GTP, LidA binding
induces striking structural remodeling around the switch I region
of Rab1(S25N), which swings from the edge of b-sheet to the
nucleotide-binding site, with the largest displacement of 9.2 A ˚ at
the Ca atom of Ile. Relocation of switch I results in formation of
an extended b-strand b2 at its N-terminal side and hydrophobic
packing against switch II (Figure 4C).
Our structural analyses suggest that LidA utilizes a similar
mechanism to GTP for maintaining Rab1 in the active
conformation. The hydrogen bonding interactions between the c
phosphate group of GTP with Thr43 and Gly69, from switch I
and switch II of Rab1 respectively, are highly conserved among
Rab proteins and important for stabilizing their active state (Figure
S2). Despite loss of the c phosphate group-mediated interactions,
the switch I region in Rab1(S25N) is stabilized through its
interaction with a7 of LidA (Figure 4D). Stabilization of the switch
II region in Rab1(S25N) is via its polar interaction with the loop
linking a6 and a7 as well as hydrophobic contacts with a5 of LidA
(Figure 4E). Deletion of the switch-stabilizing structural elements
would be expected to disfavor LidA interaction with the GDP-
bound Rab1 as compared to the GTP-bound Rab1. We therefore
quantified LidA (residues 188-449) interaction with Rab1(S25N)
and Rab1(Q70L) using an ITC assay. In support of the structure-
based prediction, the assay showed that the LidA fragment
exhibited a higher binding affinity (0.43 mM) to the GTP-bound
Rab1 than to the GDP-bound Rab1 (2.4 mM) (Figure 4F).
Interaction of Rab1-LidA shares similar features with that
of Rab4-Rabenosyn-5
Interaction of the anti-parallel coiled-coil formed by the helices
a4 and a5 with the switch and interswitch regions of Rab1 is
reminiscent of the structure of Rab4-Rabenosyn-5 complex [54].
A superposition of the overall structures of these two complexes
revealed significant structural similarity (Figure 5A). Some subtle
structural differences surrounding the switch I and II are consistent
with the notion that the switch regions adopt specific conforma-
tions in the GTP-binding form of Rab proteins [55]. Rabenosyn-5
forms a similar anti-parallel coiled-coil to LidA and binds the
Figure 3. Interaction interfaces between LidA and Rab1. (A) Rab1(S25N) is shown with electrostatic surface potentials. Blue and red represent
the positive and negative charge potential, respectively. The extensive interactions between Rab1(S25N) switch regions and LidA index finger
(smude), middle finger (wheat) and ring finger (light teal) are shown. This Figure is in the same orientation as the right panel of Figure 2B. (B) The
detailed interactions between Rab1 switch I (magentas), switch II (marine), P-loop (limon) and LidA middle finger and ring finger. (C) The detailed
interactions between Rab1 switch II and LidA index finger. The interacting residues of Rab1 and LidA are shown in sticks, residues labels are color-
coded as corresponding cartoon chains, respectively. Hydrogen bonds are indicated by black dashed lines. Salt bridge is indicated by red dashed
lines.
doi:10.1371/journal.ppat.1002528.g003
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these two peptides have reverse orientations, they contact a
significant subset of the highly conserved resides between Rab1
and Rab4, though the detailed molecular interactions differ. For
example, in both complexes the highly conserved residues
Phe48
Rab1 (Phe45
Rab4) and Trp65
Rab1 (Trp62
Rab4) are buried in
a cluster of hydrophobic residues despite their different side chain
rotamer conformations, whereas Lys61
Rab1 (Lys58
Rab4) and
Tyr80
Rab1 (Tyr77
Rab4) are involved in polar interactions
(Figures 5B,C).
LidA interacts with multiple Rabs
In addition to Rab1, LidA has been shown to be able to
interact with other Rab member proteins such as Rab6a and
Rab8b [39]. Indeed, many LidA-interacting residues in Rab1
are highly conserved in these two Rabs as well as other Rab
members (Figure 6A) suggesting that LidA may have promis-
cuity of binding Rab proteins. To further experimentally test
this, we purified 15 GST-fused Rab family members (His-fused
Rab20 is exceptional) and tested their interaction with LidA
using pull down assay. As shown in Figure 6B, thirteen out of
the fifteen Rabs tested interacted with LidA. The binding
affinities of LidA for other Rabs, including Rab2, Rab4, Rab6,
Rab7, Rab9, Rab11, Rab20 and Rab22 have been quantified
by ITC. All give KD values in the micromolar range. Compared
with them Rab1 gives the strongest binding affinity (The KD is in
nanomolar range). Thus Rab1 should be the preferred substrate
of LidA compared with other Rabs (Figure 7). Thus, although
previous LCV analysis identified interacting Rab GTPases such
as Rab1, Rab7, Rab8, and Rab14 as novel LCV components
[56], the biological relevance of the interactions await further
investigation. To make clear how LidA choose substrate from so
many Rabs, we attempted to disrupt the interactions of Rab1
and LidA by making single or double mutations of Rab1 and
LidA along the surface of the interactions. However, none of the
m u t a n t sw eh a v et e s t e db yt h ep u l l - d o w na s s a yl o s et h e i r
interaction with LidA. We also tested such mutants in other
Rabs and did not observe an effect. So it remains undetermined
how LidA selects different Rabs. Nonetheless, it is expected that
the mechanism of Rab1 recognition by LidA is applicable to
Figure 4. The complexed GDP-bound Rab1 (S25N) is held in the active conformation. (A) Superimposition of GDP-bound Rab1(S25N)-LidA
complex and GTP-bound Rab1-LidA complex (left). The Fo-Fc electron density of GDP and GTP/Mg
2+ in the two complexes is shown (right),
respectively. The Figure demonstrates the quality of the electron density (blue mesh). Both of the electron density are depicted at 3.0 s. (B)
Superimposition of LidA-bound GDP-Rab1(S25N) and LidA-bound GTP-Rab1(WT). (C) Superimposition of LidA-bound GDP-Rab1(S25N) and free GDP-
Rab1 (PDB ID code 2FOL). The largest displacement of 9.2 A ˚ at the Ca atom of Ile in Switch I is shown. The disordered broken switch II in 2FOL is
shown by blue dashed lines. The switch regions and P-loops are highlighted in different colors indicated in the color-box to contrast their
conformational changes. (D and E) The C-terminal region of LidA contributes to maintain the GDP-bound Rab1(S25N) in active conformation.
LidA(418-559) is shown with electrostatic surface potentials. (D) GDP-Rab1 switch I region is stabilized through the interaction with LidA a7 helix. (E)
Switch II region is stabilized both by polar interaction with the loop linking LidA a6 and a7 and hydrophobic contacts with LidA a5 helix; Blue and red
represent the positive and negative charge potential, white represent the hydrophobic contacts. Switch regions are color-coded as before. (F)
Quantitative analysis of two ITC runs: titration of GTP-bound Rab1(Q70L) (left) and GDP-bound Rab1(S25N) (right) into LidA(188-449), respectively.
Both titrations were performed in the absence of added Mg
2+ and GDP/GTP. The KD value is 0.43 mM for GTP-bound Rab1(Q70L) and 2.4 mM for GDP-
bound Rab1(S25N), respectively.
doi:10.1371/journal.ppat.1002528.g004
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interacting surface.
Discussion
The crystal structures presented in current study revealed that
the GDP-bound Rab1 is held in the active conformation through
associating with LidA. Consistent with this structural observation,
quantification assay using ITC demonstrated that LidA binds
strongly to both GDP- and GTP-Rab1 with a nearly equal affinity
(Figures 1A, B). These results indicate that Rab1 recognition by
LidA is independent of its cycling between GDP- and GTP-bound
states. To LidA, the switch mechanisms of Rab1 are not
operational and thus Rab1 is rendered persistently active in
interaction with LidA. Such a unique function of LidA provides
explanations for a body of previous observations.
The prenylated GDI-free Rab1(D44N) was shown to be
primarily membrane-localized, indicating that GDI is not
absolutely required for membrane targeting of Rab1 [57]. This
principle is likely applicable to the delivery of Rab1(D44N) to the
LCV [45]. The strong interaction with LidA can be important for
the membrane retention of Rab1(D44N), as LidA-deficient
mutants displayed a scattered distribution of this Rab1 mutant
in COS-1 cells [45]. Because no GDP-Rab1(D44N)-GDI complex
is formed and LidA is able to recognize GDP-Rab1, GDF and
GEF activity would be made redundant under these conditions,
providing an explanation why recruitment of Rab1(D44N) to LCV
is independent of SidM/DrrA [45]. To wild type Rab1, the
complex of GDP-Rab1-GDI is formed with a high affinity. The
direct competition of LidA with GDI for binding GDP-Rab1 will
be difficult and inefficient. Thus GDP-Rab1 has to be released
from GDI by SidM/DrrA for LidA recognition [39]. These
arguments likely hold true with the recruitment of the GDP-
restricted Rab1 mutant (S25N) to the LCV. In uninfected cells, the
dominant inhibitory effect of Rab1(S25N) derives from the
competition of this Rab1 mutant with wild type Rab1 for binding
GEFs, resulting in formation of ‘‘dead-end’’ Rab1-GEF complexes
[58]. In the case of wild type Rab1 recruitment to the LCV, this
situation could be altered, because interaction of GDP-bound
Rab1-SidM/DrrA complex is transient and much weaker than
that of GDP-bound Rab1-LidA complex [39,45] (Figure S3). LidA
is therefore expected to be able to outcompete with SidM/DrrA
for binding GDP-Rab1, which in turn facilitates the release of
GDP-Rab1 from GDF (see further discussion below). As GDP-
Rab1 is in the active conformation when complexed with LidA, it
is conceivable that Rab1(S25N) can still support the functions
performed by wild type Rab1. In complete agreement with this
hypothesis, Rab1 binding to the LCV precedes the delivery of
Sec22b, GDP-locked Rab1(S25N) can delay but not block the
recruitment of Sec22b. This Rab1 mutant can support growth of
L. pneumophila, at least for the first 10 hours of postinfection [42].
The strong association with LidA can facilitate the recruitment
of Rab1 to LCV by SidM/DrrA. Release of GDP-Rab1 from
GDIs catalyzed by SidM/DrrA (as a GDF) is a dynamic process
and GDP-Rab1-SidM/DrrA is an intermediate of the reaction
[59–61]. LidA is expected to displace SidM/DrrA from the
intermediate because of its much higher binding affinity to GDP-
Rab1, thus shifting the equilibrium toward dissociation of GDP-
Rab1-GDI complex. In this respect, LidA is similar to GTP in that
the latter is able to exchange GDP from the intermediate and form
the GTP-bound Rab1, a product that is unfavorable for
interaction with GDFs and thereby promotes disruption of
GDP-Rab1-GDI complex. It can be imagined that lack of LidA
would slow down the release of GDP-Rab1 from GDI.
Consistently, deletion of LidA resulted in delayed but not a
blocked recruitment of Rab1 to the LCV [39]. The inability of
LidA to discriminate between GDP- and GTP-bound Rab1 may
also be advantageous for L. pneumophila to retain the recruited
Rab1 on the LCV. Because even GTP-bound Rab1 is subjected to
hydrolysis by GAPs on LCV [43,44], the resulting product of
GDP-Rab1 is still able to be captured by LidA with a strong
Figure 5. Interaction of Rab1-LidA shares similar features with
that of Rab4-Rabenosyn-5. (A) Superimposition of Rab1(S25N)-
LidA(224-559) complex with Rab4-Rabenosyn-5 complex (PDB ID code
1Z0K). The superimposition of the similar anti-parallel coiled-coil
regions is shown. Rab1(S25N) is in gray and LidA is in yellow orange;
Rab4 is in light blue and Rabenosyn-5 is in green. (B and C) Similar
interfaces of the two complexes. (B) represents the detailed interactions
between Rab1(S25N) and LidA. (C) represents the detailed interactions
between Rab4 and Rabenosyn-5. The residues involved in interaction
are shown as stick representations and denoted by black labels.
doi:10.1371/journal.ppat.1002528.g005
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GDP-Rab1 less susceptible to extraction from the membrane of
LCV by GDIs, because they have to outcompete LidA for Rab1
binding.
Unlike other small GTPase effector proteins which mainly
binding to Rab1 through interacting with the switch I and II
regions that determine nucleotide-dependent interaction, LidA
holds Rab1 tightly in its hand like structure with four fingers. It is
unlikely that any Rab1 effector can displace LidA from Rab1-
LidA complex. LidA has been known to associate with the LCVs
for much longer time than SidM/DrrA. However, Rab1 does
eventually leave the LCV [44,48], so that a mechanism is needed
to decrease the binding affinity between Rab1 and LidA. Since
Rab1 is deeply buried in the complex, the most efficient way to
release Rab1 is to force LidA to open its fingers by downstream
proteins. The GTP-Rab1-LidA structure shows truncation of the
middle and the ring fingers does not disrupt Rab1-LidA complex,
so that the thumb or the index fingers, though necessary, may not
be sufficient to release Rab1 (Figure 4A). Structure analysis
indicates that the thumb and the ring finger do not pack as tightly
with other part of LidA as the index and middle finger. This
means that LidA’s wrist (the N-terminal half of a4 and b1–b4)
which is isolated from the central interacting region, the bottom of
the ring finger and thumb are accessible for other proteins to
trigger a conformational change that releases Rab1 (Figure S4).
Opening of the ring finger could be very important since it can
expose the switch region immediately to facilitate Rab1 binding by
other effectors.
Recent research showed that the post-translationally modified
Rab1b by the L. pneumophila effector protein SidM/DrrA retains
the ability to interact with LidA and can avoid the GAP
recognition [46]. Our data confirmed that the correspondent
residue Tyr80 in Rab1a was also AMPylated (Figure S5A). Tyr80
is located on the interface between Rab1a and LidA, involved in
Figure 6. 13 kinds of Rab GTPase family members could be recognized by LidA in vitro. (A) Sequence alignment of fifteen different Rabs.
The LidA-interacting residues in Rab1 are depicted by triangles. The two sequences underneath the black dashed lines correspond to the members
unbound to LidA. (B) The GST-pull down of LidA(FL) by beads-immobilized 15 kinds of GST-Rab family members, Rab20 was His-tagged for
exceptional.
doi:10.1371/journal.ppat.1002528.g006
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LidA and hydrophobic contact
with Leu406
LidA (Figure 3C), so it is reasonable to speculate that
the covalent-bound AMP group on Tyr80 will affect the stability of
LidA-Rab1 complex. However, Rab1 interacts with the LidA
palm tightly via an extensive surface, so that the interaction is
difficult to interrupt. In the structure of GTP-Rab1-LidA we can
see even the middle and the ring fingers are truncated, LidA can
still holds Rab1 (Figure 4A). Moreover the structural feature of
four fingers possesses a certain degree of flexibility. Thus the
orientations of the four fingers could adjust a little bit to
accommodate the additional AMP group. Consistent with
previous reports [46] our ITC results showed that the binding
affinity of Rab1a(K62H, 1-176) and LidA(188-580) is not
significantly affected by the AMPylation (Figure S5B,C). Thus
we presume that LidA can form both the Rab1-LidA and AMP-
Rab1-LidA complex in vivo. The ability of LidA to form stable
complex with AMPylated Rab1 is consistent with its ability to bind
a number of different Rabs, which small differences in their
surface residues. L. pneumophila may also benefit from this property.
Formation of AMPylated-Rab1-LidA complex may protect Rab1
from the de-AMPylation activity of SidD until Rab1 is released
from LidA by still unknown mechanisms.
In addition to promoting SidM/DrrA for Rab1 recruitment,
LidA may have other function(s). LidA interacts with the active
conformation of Rab1 and exhibits no enzymatic activity [39].
Structural comparison showed that binding of LidA to Rab1
shares some features of the interaction between the effector protein
Rabenosyn-5 with Rab4 [54]. Furthermore, recruitment of Rab1
is essential for delivering ER-derived vesicles to LCV [42,43,62].
Collectively, these results suggest that one potential function of
LidA is to act as an effector of Rab1 and signal downstream
components for remodeling of LCV. LidA was previously
predicted and further confirmed in the present study to be a
coiled-coil rich protein, one type of the best characterized Rab
tethering factors [27,54,63]. The terminal parallel helix forms an
antiparallel long coiled-coil and extends to the outside of
interacting region (Figure 2C). Secondary structure analysis
suggests that in full-length LidA, the length of this domain is
likely to be longer than 100 A ˚. It is thus possible that LidA may
function as a tethering factor, bridging the ER-derived vesicles and
the LCV [49]. One potential advantage of employing its own
protein as a tethering factor would allow L. pneumophila to be
selective for recruiting ER-derived components for its growth. It is
well established that a GTP-bound form of Rab GTPases interacts
with their effectors for signaling. The only exception to this rule is
Protrudin that interacts with the GDP-bound form of Rab11,
regulating Rab11-dependent membrane recycling to promote the
directional membrane trafficking [64]. While interacting with
GDP-Rab1, LidA appears to be different from protrudin in that it
essentially recognizes the active conformation of Rab1 and
probably other Rabs [39,43].
During the peer review of this manuscript, the structure of
Rab8-LidA complex was published online. Structure comparison
shows that Rab8-LidA complex adopts quite similar conforma-
tions with our structure and that the binding interface is highly
conserved, consistent with our proposal that lidA recognizes Rabs
Figure 7. Measurement of binding affinity between LidA and 9 kinds of Rabs by ITC. (A–G) Raw ITC data. Top panel: twenty injections of
Rab2 (A), Rab4 (B), Rab6 (C), Rab7 (D), Rab9 (E), Rab11 (F), Rab20 (G) solutions were titrated into LidA(188-580) solution in ITC cell. The area of each
injection peak corresponds to the total heat released for that injection. Bottom panel: the binding isotherm for these Rabs and LidA(188-580)
interaction, the integrated heat is plotted against the stoichiometry of 1:1, data fitting revealed a binding affinity as shown. (H) Raw ITC data. Top
panel: twenty injections of Rab22 (H) solutions were titrated into LidA(FL) solution ITC cell, the experiment conditions was exactly the same as the top
one unless the LidA is full-length. The KD values of these Rabs and LidA are shown.
doi:10.1371/journal.ppat.1002528.g007
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of LidA for GTP-bound Rab1 that is roughly one order of
magnitude stronger than what we measured using ITC. At this
point, it is inconsistent with our ITC data that LidA binds to both
GDP- and GTP-Rab1 with a nearly equal affinity.
Materials and Methods
Protein expression purification
The genes of lidA and sidM were amplified from genomic DNA of
Legionella pneumophila strain Corby. The DNA fragment encoding
human Rab1a (noted Rab1 throughout the text) and other 14 kinds
of Rab family members were amplified from a homemade human
cDNA library. All the genes encoding the mutant proteins were
produced using a two-step PCR procedure. LidA, both full-length
(FL) and various fragments, SidM variants include 317-545 and 1-
545 were subcloned into the pET15b (Invitrogen), Rab1 variants
and Rab2, 4, 6, 7, 8, 11, 14, 18, 23, 27 were subcloned into the
pGEX-6P-1 plasmid (GE Healthcare), Rab5, 9, 20, 22 were
subcloned into both of the two vectors. Each protein was produced
in E. coli BL21 (DE3). Cells grow at 37uC until the OD600 reach to
0.8. LidA proteins were induced with 0.5 mM isopropyl- b-D-
Thiogalactopyranoside (IPTG) for 15 h at 15uC, Rab1 and other
Rabs were all induced with 0.2 mM IPTG for 15 h at 22uC. All
proteins were purified using affinity, anion exchange and gel
filtration chromatography. To obtain LidA-Rab1 complexes, LidA
and Rab1 proteins were mixed up with a 1:1 molar ratio at 4uC for
2 hours. The LidA(188-449)-Rab1(1-191) complex and LidA(224-
559)-Rab1(S25N; 1-176) complex were further purified using the
above mentioned procedure except the GST tag and His tag were
removed by homemade PreScission protease digestion before the
anion exchange step. Both of the protein complexes have a final
concentration of 10 mg/mL. All purification processes were
performed at 4uC unless noted otherwise.
Crystallization and data collection
Crystallization conditions for complexes were determined from
the sparse matrix screen (Hampton Research). All crystals were
obtained using the hanging drop diffusion method at 20uC.
LidA(224-559)-Rab1(S25N, 1-176) complex was crystallized by
mixing equal volumes of protein with reservoir solution containing
28% Jeffamin ED-2001 and 0.1 M sodium citrate tribasic
dihydrate pH 4.8. LidA(224-559)-Rab1(S25N, 1-176) crystals
were optimized by microseeding to reach the satisfied diffraction.
LidA(188-449)-Rab1(wild-type, WT1-191) complex was crystal-
lized by mixing equal volumes of protein with reservoir solution
containing 0.1 M Hepes pH 7.5, 25% PEG3350 and 0.7%
butanol. All diffraction data were collected at Shanghai Synchro-
tron Radiation facility (SSRF) beamline BL17U. To prevent
radiation damage, crystals were equilibrated in a cryoprotectant
buffer containing 20% ethylene glycol (v/v) plus reservoir buffer
and then flash frozen in a 100 K nitrogen stream. The best crystal
of LidA(225-559)-Rab1(S25N; 1-176) complex diffracted to
1.73 A ˚. The best crystal of LidA(188-449)-Rab1(WT; 1-191)
complex diffracted to 2.2 A ˚. Data sets were processed using the
HKL2000 software suite [65].
Structure determination
The crystal structures of the two kinds of LidA-Rab1 complexes
were determined by molecular replacement using PHASER [66]
with the coordinates of Rab1 as the searching models (PDB ID
code 2FOL) [67]. The atomic models were built using COOT
[68] and refined using PHENIX [69]. Data collection and
structure refinement statistics are summarized in Table S1. A
SA-composite omit map of LidA index finger shows the good
match between the atom skeleton and the electron density map as
supplementary Figure S6. All the molecular graphics Figures were
generated using PyMol (http://www.pymol.org).
Isothermal titration calorimetry
ITC was employed to measure the binding affinities of various
fragments of LidA with Rab1 variants and 9 kinds of Rabs. All
protein samples were purified in a buffer containing 20 mM Hepes
(pH 8.0) and 100 mM NaCl with tag removed by PreScission
protease digestion. The final concentration of LidA(188-580) and
LidA(188-449) were 0.2 mM, Rab1(S25N) and Rab1(Q70L) were
2 mM, LidA(FL) was 0.15 mM, Rabs(FL) (include 2, 4, 6, 7, 9, 11,
20, 22) were 1.5 mM. The samples were centrifuged to remove
any precipitate before the experiments. All measurements were
carried out at 25uC by using a VP-ITC microcalorimeter 200
(MicroCal). Titrations were carried out by titrating Rab1(S25N)
and Rab1(Q70L) into LidA(188-580) or LidA(188-449), respec-
tively. Rab2, 4, 6, 7, 9, 11, 20 proteins were titrated into LidA(188-
580). Rab22 were titrated into LidA(FL). The titration Data were
analyzed using ORIGIN data analysis software (MicroCalSoft-
ware).
In vitro pull down assay
15 kinds of purified Rab family members (WT; FL) with N-
terminal GST tag (His-fused Rab20 is exceptional) was immobi-
lized onto 200 mL glutathione-Sepharose resin (GE) or Ni-
chelating sepharose (GE healthcare) for His-Rab20. The resin
was then washed three times to remove excess unbound protein.
Untagged LidA(FL) protein solution was loaded onto the Rabs-
immobilized beads and incubated at 4uC for 2 h. The loaded
protein dose of LidA and Rabs was at a molar ratio of 2:1. The
resin was washed three times using the wash buffer (25 mM Tris-
HCl buffer pH 8.0, 100 mM NaCl) to remove unbound LidA.
Proteins binding to the resin were eluted by elution buffer (25 mM
Tris-HCl buffer pH 8.0, 100 mM NaCl, 3 mM DTT, 5 mM
GSH for glutathione-Sepharose resin and 25 mM Tris-HCl buffer
pH 8.0, 100 mM NaCl, 250 mM imidazole for Ni-chelating
sepharose). All samples were subjected to SDS-PAGE which was
visualized by Coomassie Brilliant Blue staining.
Accession numbers
Crystal structure of LidA(224-559)-Rab1(S25N; 1-176) complex
and the structure factor have been deposited in the Protein Data
Bank (http://www.rcsb.org/pdb) under ID codes 3SFV. Crystal
structure of LidA(188-449)-Rab1(Q70L; 1-191) complex and the
structure factor are deposited with access codes 3TKL.
Supporting Information
Figure S1 Domain mapping of LidA. (A) Schematic
representation of LidA fragments used in minimal domain
mapping assay, numbers indicate amino acid residues, the
corresponding binding affinity are labeled by plus/minus marker.
(B) Gel filtration assay for LidA fragments-Rab1 complex
formation. The proteins of Rab1(Q70L), LidA(FL) and variants
were subject to gel filtration. Aliquots of the peak fraction
corresponding to the position of LidA-Rab1 complex were
subjected to SDS-PAGE which were visualized by Coomassie
Brilliant Blue staining.
(TIF)
Figure S2 Representation of 5 related GTP or GTP
analogue-bound Rab GTPase structures. (A) Left: cartoon
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from the LidA(188-449)-Rab1(WT; 1-191) complex. Right: the
hydrogen bonds between GTP phosphate group and Gly69,
Thr43 in the structure of GTP-bound Rab1 complexed with LidA.
The GTP-Rab1 is shown in pink; the switch I, switch II and P-
loop are shown in red, purple and green, respectively. (B–E)
Cartoon representation of GppNHp-bound Ypt1 (PDB ID CODE
1YZN) (B), GTP-bound Rab4 (PDB ID CODE 1Z0K) (C), GTP-
bound Rab6 (PDB ID CODE 2GIL) (D) and GTP-bound Rab7
(PDB ID CODE 1T91) (E), respectively. The conserved hydrogen
bonding interactions among GTP (or GTP analogue GppNHp)
and switch regions are denoted on the structure by black dashed
lines. All structures are shown in the same orientation. Switch I,
Switch II, P-loop and Mg
2+ are indicated by the colors as shown.
GTP (or GTP analogue GppNHp) are shown as sticks, Mg
2+ is
shown as sphere, the length of the conserved hydrogen bonds are
indicated.
(TIF)
Figure S3 SidM(317-545)-Rab1(1-176) complex disasso-
ciation induced by LidA and nucleotides. The SidM(317-
545)-Rab1(1-176) complex was mixed with LidA(191-600) at a
molar ratio of 1:5 and subjected to gel filtration in presence of
5 mM GDP (gray lines) or GTP (black lines); The same mixture in
absence of nucleotides is shown as red lines. All samples were
analyzed by size exclusion chromatography on a Superdex-200
column, monitored by UV absorption at 280 nm, the peak elution
volumes are labeled as shown. The formation of LidA(191-600)-
Rab1(1-176) complexes were observed only in presence of the
nucleotides.
(TIF)
Figure S4 LidA potential interface for downstream
effectors. Cartoon representation of the LidA structural interface
to potential effectors. Rab1(S25N) and the switch regions, and
LidA’s fingers are color-coded the same as Figure 2. Double arrow
points to the LidA-Rab1 interacting gab and switch regions,
respectively. LidA’s potential structural interaction domains with
downstream effector exist in two regions, labeled as the arrow
point. Since the key interaction regions with cellular ligands of
Rab1 known as switch I and II are occupied by LidA and buried
inside the complex, it is hard for other Rab effectors to replace the
LidA for Rab1 binding, thus the bottom of the ring finger in LidA,
labeled as ‘‘LidA interaction region 1’’, and the wrist (the N-
terminal half of a4 and b1–b4) which is isolated from the central
interacting region, labeled as ‘‘LidA interaction region 2’’, are
accessible for other proteins to bind with LidA and may cause
allosteric effect on these fingers to release Rab1.
(TIF)
Figure S5 Rab1 AMPylation cause no effect to LidA-
binding ability in vitro. (A) Mass spectrometry analysis of
Rab1a(K62H,1-176) show LidA has no influence on Rab1a
AMPylation reaction in vitro. MALDI-TOF reflector spectra of
tryptic digestion of three samples. (Top) Unmodified Ra-
b1a(K62H,1-176), this mutant can eliminate the 1317 daltons
mass peak 62LQIWDTAGQER72 in native Rab1 which cause
superposition with the peak of the AMPylated 75TITSSY-AM-
PYR82 peptide (1319 daltons). (Middle) AMPylated Ra-
b1a(K62H,1-176) treated by SidM(1-545) for 4 h. The inset in
zoom showing the intensity of 75TITSSYYR82 peptide at m/z
990, and the existence of AMPylated peptide 75TITSSY-AMPYR82
at m/z 1319. (Bottom) AMPylated Rab1a(K62H,1-176) treated by
both SidM(1-545) and LidA(FL). Both peptide at m/z 1319 and
m/z 990 have no significant mass shift compared with the one
shown in middle mass spectrum Figure. The insets show
magnification of the peaks around m/z 990 and 1319. (B)
Measurement of binding affinity between LidA(188-580) and
unmodified Rab1a(K62H,1-176) by ITC. Top panel: twenty
injections of Rab1a(K62H,1-176) solutions were titrated into
LidA(188-580) solution ITC cell. The area of each injection peak
corresponds to the total heat released for that injection. Bottom
panel: the binding isotherm for Rab1a(K62H,1-176) and
LidA(188-580) interaction, the integrated heat is plotted against
the stoichiometry in 1:1, data fitting revealed a binding affinity as
shown. (C) Measurement of binding affinity between LidA(188-
580) and AMPylated Rab1a(K62H,1-176) by ITC, the experiment
conditions was exactly the same as B unless the Rab1a(K62H,1-
176) is AMPylated before the titration.
(TIF)
Figure S6 Representative the composite omit map of
LidA index finger. The SA-composite map of LidA(385-455) in
the LidA-Rab1(S25N) complex. This part is a bit longer than the
index finger (from 387 to 449), the corresponding sequence is
shown. The Figure demonstrates the quality of the electron density
(blue mesh). Both of the electron densities are depicted at 1.5 s.
(TIF)
Protocol S1 Domain mapping by gel filtration. To map
the interaction domain of LidA with Rab1, the proteins of
LidA(FL) and fragments, Rab1(FL, Q70L) were purified by affinity
chromatography with N-terminal His-tag, then mixed protein
solutions together at 4uC for 2 h, the protein concentration of
Rab1 and LidA was at a molar ratio of 1:1. Afterwards, the protein
mixtures were subject to size exclusion chromatography on a
Superdex-200, monitored by UV absorption at 280 nm. The
buffer of gel filtration containing 25 mM Tris-HCl (pH 8.0),
100 mM NaCl, and 3 mM DTT. Each aliquots of the peak
fraction were subjected to SDS-PAGE which were visualized by
Coomassie Brilliant Blue staining.
(DOCX)
Protocol S2 In vitro AMPylation of Rab1a(K62H, 1-176)
and purification of AMP-Rab1a(K62H, 1-176). Ra-
b1a(K62H,1-176) protein was AMPylated in the presence of 2.5
molar excess of ATP and 0.01 molar ratio of SidM at room
temperature for 4 h, afterwards, the AMPylated Rab1a(K62H,1-
176) was purified by gel filtration on a Superdex-200 10/300
column (GE healthcare) at 4uC. Fractions containing AMPylated
Rab1a(K62H,1-176) in 20 mM Hepes (pH 8.0), 100 mM NaCl
were pooled, concentrated to 1.5 mM, and stored at 280uC.
Completeness of AMPylated Rab1a was verified by mass
spectrometry as described in mass spectrometry.
(DOCX)
Protocol S3 Mass spectrometry. Rab1a(K62H,1-176) pro-
tein was separated by SDS-PAGE gel, and Coomassie brilliant
blue stained. The in-gel digestion of Rab1a(K62H,1-176) for mass
spectrometric analysis was performed as published previously [1].
Peptides were dissolved with 0.5% trifluoroacetic acid from digest
mixture, and peptide mass analysis was performed using AB4700
MALDI-TOF/TOF mass spectrometer (Applied Biosystems). All
data were acquired in the positive ion mode over an m/z range of
500–2000 Da.
(DOCX)
Protocol S4 Isothermal titration calorimetry. ITC was
employed to measure the binding affinities of LidA(188-580) with
Rab1a(K62H,1-176) or AMPylated Rab1a(K62H,1-176). All
protein samples were purified in a buffer containing 20 mM Hepes
(pH 8.0) and 100 mM NaCl. The final concentration of LidA(188-
580) were 0.12 mM, Rab1a(K62H,1-176) and AMPylated
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to remove any precipitate before the experiments. Both titrations
were performed in the absence of added Mg
2+ and ATP. All
measurements were carried out at 25uC by using a VP-ITC
microcalorimeter 200 (MicroCal). Titrations were carried out by
titrating Rab1a(K62H,1-176) or AMPylated Rab1a(K62H,1-176)
into LidA(188-580), respectively; The titration Data were analyzed
using ORIGIN data analysis software (MicroCalSoftware).
(DOCX)
Table S1 Data collection and structure refinement
statistics.
(DOCX)
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